Panagiota Zerva

Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?

K. Stamatopoulos, D. Margaritis, I. Kotsianidis, 2019, Leukemia & lymphoma.

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia

A. Anagnostopoulos, E. Gavriilaki, A. Papalexandri, 2018, HemaSphere.

Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?

M. Papathanasiou, A. Anagnostopoulos, A. Athanasiadou, 2018, HemaSphere.

Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes

E. Yannaki, A. Anagnostopoulos, C. Demosthenous, 2023, International journal of molecular sciences.